Is Berberine a GLP-1 Receptor Agonist
13-15 The Swedish national diabetes registry has shown that good control of diabetes and CV risk factors negates the increased risk of atherosclerotic disease, but there remains a significant excess risk of hospitalisation for HF
doi: 10.1111/1753-0407.12891 Summary Keywords diabetic kidney disease, diabetic nephropathy, GLP-1 receptor agonists, liraglutide, semaglutide, dulaglutide Citation Kawanami D and Takashi Y (2020) GLP-1 Receptor Agonists in Diabetic Kidney Disease: From Clinical Outcomes to Mechanisms
Efficacy and cardiovascular safety of GLP-1 receptor analogues
Reduced blood pressure GLP-1 and weight loss injections in Basking Ridge, New Jersey GLP-1 and weight loss injections is one of the hottest new weight-loss treatments on the market
If you have additional questions, Anita Petruzzelli, M.D